Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial

Clinical trial NCT02305134 · COMPLETED

Trial details

NCT number: NCT02305134
Sponsor: Chiba University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Attention Deficit Disorder With Hyperactivity Disease Hyperkinesis Attention Deficit and Disruptive Behavior Disorders

Start date: 2015-06-11
Primary completion: 2019-03-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.